Adalta Ltd. has released a press release.
US FDA grants EW-001 pre-IND meeting
Earlier from Adalta
- Oribiotech deal validates AdAlta manufacturing strategy
- BZDS1901 special access scheme launch in China
- EW-001 IIT study overall survival update
- 2 year survival milestone for EW-001 patient